Orla Protein Technologies’ Industrial CASE student Tim Robson has presented his latest results on the oriented assembly of engineered outer membrane proteins on the surface of immobilised gold nanoparticles. A poster describing this work was Continue Reading
We are experts in sticking proteins to surfaces whilst retaining near 100% function
Proteins for functionalisation of biosensors, cell culture ware, bioprocess media and more
Our protein engineering experts will help you develop new products and processes and improve existing ones
We welcome partnering and licensing enquiries for access to our technology and expertise
Since its foundation in 2003, Orla Protein Technologies has built a solid reputation in the Life Sciences Industry through cutting-edge research and a commitment to innovation. We focus upon recombinant protein design, engineering and manufacture particularly for surface applications.
We provide technology, products and bespoke contract services and are continually seeking new partnerships and collaborations. Our patented protein engineering platform, OrlaSURF, can be readily transferred, and is used commercially in a diverse range of Life Science applications such as bioanalytical devices, cell culture, bioseparations, and assay development. We enable improved performance, efficient manufacture, reproducibility, reliability, and ultimately, superior products. Read more
Latest News from Orla
Orla Protein Technologies Ltd, a leader in the design, engineering and immobilisation of proteins for surface applications, has been granted U.K. patent No. GB2527623 to its novel protein engineering and immobilisation platform (OrlaSURF) for immobilisation Continue Reading
Speed-to-clinic and then speed-to-market are highly significant metrics for companies developing biopharmaceuticals. In the article “Analytical tools to improve decision-making during antibody-drug-conjugate development” Dr Nick Hutchinson describes why it would be a mistake to underestimate the Continue Reading
Article featured in BioProcess International. Next generation drug products bring new challenges for analytics and biomanufacture. Tools available for well-established processes are not optimal for next-generation drug products including non-antibody protein drugs, biosimilars and antibody Continue Reading
Publication reveals further insight into bacterial outer membrane biochemistry Bacterial outer membrane proteins are inherent to the OrlaSURF protein engineering platform that is finding commercial application in cell culture, diagnostics, analytical biosensors, and bioprocessing. Meanwhile, Continue Reading
OrlaExplorer plates allow researchers to discover the best growth surface for their cells and then use that exact same surface reliably over a wide range of formats such as well plates, flasks and micro-carrier beads.